Endpoint definition
↥Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
pancreatic neuroendocrine tumor: Pancreatic endocrine tumor, also known as pancreatic neuroendocrine tumor (PNET), describes a group of endocrine tumors originating in the pancreas that are usually indolent and benign, but may have the potential to be malignant. They can be functional, exhibiting a hormonal hypersecretion syndrome, but can be non-functional presenting with non-specific symptoms and include insulinoma, glucagonoma, VIPoma, somatostatinoma (SSoma), PPoma and Zollinger-Ellison syndrome (ZES, or gastrinoma) and other ectopic hormone producing tumors (such as GRFoma) (see these terms).
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Include endpoints None
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to Benign neoplasm: Endocrine pancreas based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
None
All | Female | Male | |
---|---|---|---|
Number of individuals | 73 | 30 | 43 |
Unadjusted prevalence (%) | 0.03 | 0.02 | 0.04 |
Mean age at first event (years) | 60.18 | 54.50 | 64.14 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | - | - | - | - |
15 years | - | - | - | - |
5 years | - | - | - | - |
1 year | - | - | - | - |
Index endpoint: CD2_BENIGN_ENDOCRINE_PANCREAS – Benign neoplasm: Endocrine pancreas
GWS hits:
before Benign neoplasm: Endocrine pancreas
after Benign neoplasm: Endocrine pancreas
Loading survival analyses plot
Loading survival analyses table